Nike's 2025 Comeback: How the Sneaker Stock Is Approaching Break-Even

Nike's stock (NKE) has substantially rebounded from its April lows of $54 to nearly $71, reflecting increased investor confidence in its turnaround plan under CEO Elliott Hill. This recovery, which has brought the stock close to its 2025 break-even, is driving heightened analyst optimism, with firms like Baird now forecasting triple-digit price targets ($100+) over the next 18-24 months. Analysts cite improvements in inventory, sales quality, and product innovation ahead of the anticipated quarterly update, though some caution remains regarding gross margins and tariffs.

Analysis

Nike's (NKE) stock has demonstrated a significant recovery, rebounding from its April low of below $54 to just under $71, signaling renewed investor confidence in the company's turnaround strategy under CEO Elliott Hill. This rally has brought the stock close to its break-even point for 2025, although it remains over a third below its 2023 closing price. The positive sentiment is increasingly shared by Wall Street, with Baird designating the stock a "fresh pick" and setting an $88 price target, citing the potential for Nike to beat its own guidance of a "mid-single digits" revenue decline in the upcoming fiscal first quarter. Baird's optimism is predicated on improved inventory levels, sales quality, and product innovation, and they project a long-term path to the low-to-mid $100s over 18-24 months. However, this bullish outlook is not universal. Bank of America holds a more cautious $84 target, flagging concerns over gross margins due to tariffs, while Morgan Stanley's target is only $70. The mean analyst price target of just over $80 implies a modest 13% premium, highlighting the divergence in expectations ahead of next week's crucial quarterly update.

Key Decisions for Investors

• Investors aligned with the bullish turnaround narrative may consider the stock's momentum and positive analyst revisions as an opportunity, especially focusing on the upcoming earnings report for validation of improved inventory and sales quality.
• Given the stock's substantial recovery from its lows and the modest 13% premium implied by the mean price target, a cautious approach is warranted; key risks to monitor include potential gross margin compression from tariffs, as highlighted by Bank of America.
• The upcoming quarterly results are a pivotal catalyst, and positions should be assessed based on whether the company beats its own FQ1 revenue guidance and provides concrete evidence that the turnaround is taking hold.